专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US07087433B2 7SK RNA regulated transcription 有权
标题翻译： 7SK RNA调节转录
公开(公告)号：US07087433B2
公开(公告)日：2006-08-08
申请号：US10227367
申请日：2002-08-25
申请人： Qiang Zhou , Zhiyuan Yang , Qingwei Zhu , Kunxin Luo
发明人： Qiang Zhou , Zhiyuan Yang , Qingwei Zhu , Kunxin Luo
IPC分类号： A61K48/00 , C07H21/04 , C07H21/02 , C12Q1/68
CPC分类号： C12N15/113
摘要： A method for altering transcription in a cell comprising an amount of active CDK9/cyclin, comprises the steps of: (a) introducing in the cell an agent which modulates the amount of active CDK9/cyclin in the cell, and thereby alters transcription in the cell, wherein the agent comprises an RNA selected from the group consisting of an RNA aptamer that specifically binds CDK9/cyclin, a CDK9/cyclin-binding domain of 7SK RNA, a 7SK RNA-binding antisense 7SK RNA domain, and a 7SK RNA-specific RNAi, and (b) detecting a resultant altering of transcription in the cell.Methods for screening for an agent which modulates 7SK RNA-CDK9/cyclin binding generally comprise the steps of (a) incubating a mixture of 7SK RNA, CDK9/cyclin and a candidate agent under conditions wherein but for the presence of the agent, the 7SK RNA and CDK9/cyclin engage in a reference binding; and (b) detecting an agent-biased binding of the 7SK RNA to the CDK9/cyclin.
摘要翻译：一种用于在包含一定量活性CDK9 /细胞周期蛋白的细胞中改变转录的方法包括以下步骤：（a）在细胞中引入调节细胞中活性CDK9 /细胞周期蛋白的量的试剂，从而改变细胞内的转录细胞，其中所述试剂包含选自特异性结合CDK9 /细胞周期蛋白的RNA适配体，7SK RNA的CDK9 /细胞周期蛋白结合结构域，7SK RNA结合反义7SK RNA结构域和7SK RNA- 特异性RNAi，和（b）检测所得到的细胞转录的变化。用于筛选调节7SK RNA-CDK9 /细胞周期蛋白结合的试剂的方法通常包括以下步骤：（a）在7SK RNA，CDK9 /细胞周期蛋白和候选试剂的混合物的条件下， RNA和CDK9 /细胞周期蛋白参与参考结合; 和（b）检测7SK RNA与CDK9 /细胞周期蛋白的药剂偏置结合。

2. 发明申请

US20060239976A1 75K RNA regulated transcription 审中-公开
标题翻译： 75K RNA调节转录
公开(公告)号：US20060239976A1
公开(公告)日：2006-10-26
申请号：US11481190
申请日：2006-07-01
申请人： Qiang Zheu , Zhiyuan Yang , Qingwei Zhu , Kunxin Luo
发明人： Qiang Zheu , Zhiyuan Yang , Qingwei Zhu , Kunxin Luo
IPC分类号： A61K48/00 , C12N15/867
CPC分类号： C12N15/113
摘要： A method for altering transcription in a cell comprising an amount of active CDK9/cyclin, comprises the steps of: (a) introducing in the cell an agent which modulates the amount of active CDK9/cyclin in the cell, and thereby alters transcription in the cell, wherein the agent comprises an RNA selected from the group consisting of an RNA aptamer that specifically binds CDK9/cyclin, a CDK9/cyclin-binding domain of 7SK RNA, a 7SK RNA-binding antisense 7SK RNA domain, and a 7SK RNA-specific RNAi, and (b) detecting a resultant altering of transcription in the cell. Methods for screening for an agent which modulates 7SK RNA-CDK9/cyclin binding generally comprise the steps of (a) incubating a mixture of 7SK RNA, CDK9/cyclin and a candidate agent under conditions wherein but for the presence of the agent, the 7SK RNA and CDK9/cyclin engage in a reference binding; and (b) detecting an agent-biased binding of the 7SK RNA to the CDK9/cyclin.
摘要翻译：一种用于在包含一定量活性CDK9 /细胞周期蛋白的细胞中改变转录的方法包括以下步骤：（a）在细胞中引入调节细胞中活性CDK9 /细胞周期蛋白的量的试剂，从而改变细胞内的转录细胞，其中所述试剂包含选自特异性结合CDK9 /细胞周期蛋白的RNA适配体，7SK RNA的CDK9 /细胞周期蛋白结合结构域，7SK RNA结合反义7SK RNA结构域和7SK RNA- 特异性RNAi，和（b）检测所得到的细胞转录的变化。用于筛选调节7SK RNA-CDK9 /细胞周期蛋白结合的试剂的方法通常包括以下步骤：（a）在7SK RNA，CDK9 /细胞周期蛋白和候选试剂的混合物的条件下， RNA和CDK9 /细胞周期蛋白参与参考结合; 和（b）检测7SK RNA与CDK9 /细胞周期蛋白的药剂偏置结合。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式